NexImmune's market cap is currently $279.00. The company's EPS TTM is $-244.272; its P/E ratio is ―; NexImmune is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
